News
At Cell-Easy, we provide end-to-end GMP manufacturing services for advanced therapy medicinal products (ATMPs), with a strong focus on compliance, scalability, and reliability.
We help biotech and pharma companies bring innovative cell therapies from the lab to the clinic by combining high-quality starting material sourcing, robust process development, and clinical-grade GMP production that meets international standards (MHRA, ANSM, EMA, FDA readiness).
Whether you need early clinical batches or large-scale production, our tailored solutions optimize your process, minimize risks, and accelerate time-to-clinic.
IMPD Approval for FIH Trial in Systemic Sclerosis – Cell Easy
Learn more: IMPD Approval for FIH Trial in Systemic Sclerosis – Cell EasyIMPD Approval for FIH Trial in Systemic Sclerosis – Cell Easy EU regulatory approval to administer Adipose-derived mesenchymal Stem Cells
Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer
Learn more: Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific OfficerCell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer Cell-Easy, a specialized contract
IUCT-Oncopole and Cell-Easy sign a MOU to accelerate cancer patient access to advanced cell-based therapy
Learn more: IUCT-Oncopole and Cell-Easy sign a MOU to accelerate cancer patient access to advanced cell-based therapyIUCT-Oncopole and Cell-Easy sign a MOU to accelerate cancer patient access to advanced cell-based therapy IUCT-Oncopole – Nouvelle fenêtre and Cell-Easy announced today the
Cell-Easy Appoints CDMO Expert Dr. Ribault to Its Board
Learn more: Cell-Easy Appoints CDMO Expert Dr. Ribault to Its BoardCell-Easy Appoints CDMO Expert Dr. Ribault to Its Board Cell-Easy is a leading contract development and manufacturing organization (CDMO) with
EMERCell & Cell-Easy sign a Strategic Agreement for the Scale-up and Manufacturing of NK-001
Learn more: EMERCell & Cell-Easy sign a Strategic Agreement for the Scale-up and Manufacturing of NK-001EMERCell & Cell-Easy sign a Strategic Agreement for the Scale-up and Manufacturing of NK-001 Emercell has selected Cell-Easy as a
Cell-Easy Launches OPTI-STEM for Cell Therapy Access
Learn more: Cell-Easy Launches OPTI-STEM for Cell Therapy AccessCell-Easy Launches OPTI-STEM for Cell Therapy Access The OPTI-STEM consortium led by CDMO Cell-Easy receives €7M from the French government